Christopher Hite
Director; EVP & Chairman, Partnering; EVP & Vice Chairman · 9 filings · Latest: Sep 22, 2026
Kailera Therapeutics, Inc.
Royalty Pharma plc
Vera Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RPRX | Christopher Hite | EVP & Chairman, Partnering | Sep 22, 2026 | Sale | $58.53 | 100,000 | $5.9M | 270,401 | |
RPRX | Christopher Hite | EVP & Chairman, Partnering | Aug 18, 2026 | Sale | $59.97 | 100,000 | $6.0M | 370,401 | |
RPRX | Christopher Hite | EVP & Chairman, Partnering | Jun 30, 2026 | Sale | $56.50 | 130,000 | $7.3M | 40,000 | |
RPRX | Christopher Hite | EVP & Chairman, Partnering | Jun 23, 2026 | Sale | $54.40 | 150,000 | $8.2M | 559,399 | |
RPRX | Christopher Hite | — | Jun 23, 2026 | Proposed Sale | $55.35 | 30,000 | $1.7M | — |